Sun Pharmaceutical Industries Limited Share Price Today
Techno Funda Ratings
Key Metrics
Current Price
₹1950.1Market Cap
₹ 4,63,695 Cr.Stock P/E
37.3ROE
16.0 %RSI
65.84Trend
BullishShare Price Chart
Technical Commentary
Buy or Sell Analysis
Company Overview
Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to global market.[1] It is the largest pharmaceutical company in India.[2]
Sun Pharmaceutical Industries Ltd share price remains one of the actively tracked stocks on NSE among traders and long term investors.
The latest Sun Pharmaceutical Industries Ltd share price NSE movement reflects ongoing investor interest driven by company fundamentals, sector performance and broader market sentiment.
From a technical analysis perspective, the Sun Pharmaceutical Industries Ltd share price chart currently indicates a Bullish trend based on moving averages and RSI momentum analysis.
Technical Analysis
| Indicator | Value |
|---|---|
| Current Price | 1950.1 |
| RSI (14) | 65.84 |
| 50 DMA | 1854.88 |
| 200 DMA | 1757.98 |
| Trend | Bullish |
| A/D Rating | B |
| RS Rating | 76 |
| EPS Rating | 37 |
| TI65 | 1.06 |
| TI65 Trend | Bullish |
Pivot Points Analysis
Daily pivot points for Sun Pharmaceutical Industries Limited calculated using previous trading session data. These levels help traders identify intraday support, resistance and breakout zones using Classic Pivot Point methodology.
Classic Pivot Points
| Level | Value |
|---|---|
| R3 | ₹1981.1 |
| R2 | ₹1971.9 |
| R1 | ₹1961.7 |
| PP | ₹1952.5 |
| S1 | ₹1942.3 |
| S2 | ₹1933.1 |
| S3 | ₹1922.9 |
Financial Ratios
| Metric | Value |
|---|---|
| Market Cap | ₹ 4,63,695 Cr. |
| Current Price | ₹ 1,933 |
| High / Low | ₹ 1,963 / 1,547 |
| Stock P/E | 37.3 |
| Book Value | ₹ 348 |
| Dividend Yield | 0.83 % |
| ROCE | 20.5 % |
| ROE | 16.0 % |
| Face Value | ₹ 1.00 |
Quarterly Results
| Quarter | Sales | Profit | OPM |
|---|---|---|---|
| Mar 2023 | 10,931 | 1,983 | 26% |
| Jun 2023 | 11,941 | 2,006 | 28% |
| Sep 2023 | 12,192 | 2,385 | 26% |
| Dec 2023 | 12,381 | 2,561 | 28% |
| Mar 2024 | 11,983 | 2,659 | 25% |
| Jun 2024 | 12,653 | 2,861 | 29% |
| Sep 2024 | 13,291 | 3,037 | 30% |
| Dec 2024 | 13,675 | 2,913 | 29% |
| Mar 2025 | 12,959 | 2,154 | 29% |
| Jun 2025 | 13,851 | 2,293 | 31% |
| Sep 2025 | 14,478 | 3,125 | 31% |
| Dec 2025 | 15,521 | 3,381 | 32% |
| Mar 2026 | 14,612 | 2,710 | 27% |
Shareholding Pattern
| Holder | Holding |
|---|---|
| Promoters | 54.39% |
| FIIs | 21.28% |
| DIIs | 12.21% |
| Government | 0.00% |
| Public | 12.13% |
| No. of Shareholders | 5,71,998 |
Pros and Cons
Pros
- Healthy return on equity of 16% indicating strong capital allocation efficiency.
- Strong technical momentum with price holding comfortably above the 50 DMA (1854.88).
- Outperforming over 70% of the entire market universe over the past 12 months.
Cons
Related NSE Stocks
PNB Housing Finance Limited
View Share Price Analysis →The Ramco Cements Limited
View Share Price Analysis →Bharat Petroleum Corporation Limited
View Share Price Analysis →JSW Energy Limited
View Share Price Analysis →Berger Paints (I) Limited
View Share Price Analysis →IndusInd Bank Limited
View Share Price Analysis →Inox Wind Limited
View Share Price Analysis →Action Construction Equipment Limited
View Share Price Analysis →ACC Limited
View Share Price Analysis →Prestige Estates Projects Limited
View Share Price Analysis →Reliance Power Limited
View Share Price Analysis →Redington Limited
View Share Price Analysis →Frequently Asked Questions
What is the current technical trend and RSI for Sun Pharmaceutical Industries Ltd share?
Based on the latest closing data, the technical momentum for Sun Pharmaceutical Industries Ltd is currently evaluated as Bullish. The stock is exhibiting an RSI (14) of 65.84, indicating it is trading in a neutral balanced zone. Key tracking supports are currently located near the daily pivots, with price relative to the 50 DMA (1854.88) defining immediate multi-day trend patterns.
What are the key resistance and support pivot points for Sun Pharmaceutical Industries Ltd?
According to Classic Pivot Point methodologies, the core trading floor for Sun Pharmaceutical Industries Ltd today centers at a Pivot Point (PP) of ₹1952.5. Upside resistance challenges are calculated at R1: ₹1961.7, R2: ₹1971.9, and R3: ₹1981.1. Conversely, if selling pressure intensifies, immediate floor support targets are positioned at S1: ₹1942.3, S2: ₹1933.1, and S3: ₹1922.9.
How does the fundamental ROE and P/E ratio look for Sun Pharmaceutical Industries Ltd?
Sun Pharmaceutical Industries Ltd is currently trading with a valuation metrics context of a Stock P/E of 37.3, against a core structural efficiency Return on Equity (ROE) standing at 16.0 %. This fundamental operational efficiency baseline is coupled with an EPS Rating of 37, allowing investors to track how corporate profitability trends align with current price discovery cycles on the National Stock Exchange (NSE).
Should I buy or sell Sun Pharmaceutical Industries Ltd shares based on corporate rankings?
Our dynamic trade matrix suggests a status of: Speculative Momentum Phase (Neutral / Hold). Sun Pharmaceutical Industries Ltd i... For long-term portfolios, decision-making should match the stock's market performance profile, which currently displays an institutional Accumulation/Distribution (A/D) grade of B, a Relative Strength (RS) ranking of 76, and long-term trend backing from the TI65 indicator (Bullish pattern).